Balchem BCPC Royalty Revenue — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Balchem in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Balchem's royalty revenue — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Balchem's royalty revenue — net sales?
- Balchem (BCPC) reported royalty revenue — net sales of $493K in Q1 2026.
- How has Balchem's royalty revenue — net sales changed year-over-year?
- Balchem's royalty revenue — net sales increased by 7.6% year-over-year, from $458K to $493K.
- What is the long-term trend for Balchem's royalty revenue — net sales?
- Over 4 years (2021 to 2025), Balchem's royalty revenue — net sales has grown at a -19.5% compound annual growth rate (CAGR), from $4.51M to $1.89M.
- What does royalty revenue — net sales mean?
- This metric represents the total net sales generated specifically from royalty-based licensing agreements or intellectual property utilization within the company's portfolio. It captures recurring income streams derived from allowing third parties to use proprietary technology, formulations, or brand assets in exchange for periodic payments. Monitoring this figure helps investors assess the company's ability to monetize its intangible assets and intellectual property independently of direct product manufacturing and distribution.